|
Name |
Cajanol
|
| Molecular Formula | C17H16O6 | |
| IUPAC Name* |
5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one
|
|
| SMILES |
COC1=CC(=C2C(=C1)OCC(C2=O)C3=C(C=C(C=C3)O)OC)O
|
|
| InChI |
InChI=1S/C17H16O6/c1-21-10-6-13(19)16-15(7-10)23-8-12(17(16)20)11-4-3-9(18)5-14(11)22-2/h3-7,12,18-19H,8H2,1-2H3
|
|
| InChIKey |
RYYWWFXWFMYKJM-UHFFFAOYSA-N
|
|
| Synonyms |
Cajanol; 61020-70-0; U192S21MNA; UNII-U192S21MNA; SCHEMBL571648; DTXSID00976519; LMPK12050499; 5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one; 2,3-DIHYDRO-5-HYDROXY-3-(4-HYDROXY-2-METHOXYPHENYL)-7-METHOXY-4H-1-BENZOPYRAN-4-ONE; XC161666; 4',5-Dihydroxy-2',7-dimethoxyisoflavanone; 5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7 -methoxychroman-4-one; 5-Hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxy-2,3-dihydro-4H-1-benzopyran-4-one; 4H-1-BENZOPYRAN-4-ONE, 2,3-DIHYDRO-5-HYDROXY-3-(4-HYDROXY-2-METHOXYPHENYL)-7-METHOXY-
|
|
| CAS | 61020-70-0 | |
| PubChem CID | 442670 | |
| ChEMBL ID | CHEMBL1689287 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 316.3 | ALogp: | 2.9 |
| HBD: | 2 | HBA: | 6 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 85.2 | Aromatic Rings: | 3 |
| Heavy Atoms: | 23 | QED Weighted: | 0.904 |
| Caco-2 Permeability: | -4.812 | MDCK Permeability: | 0.00001850 |
| Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.05 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.01 |
| 30% Bioavailability (F30%): | 0.047 |
| Blood-Brain-Barrier Penetration (BBB): | 0.038 | Plasma Protein Binding (PPB): | 98.58% |
| Volume Distribution (VD): | 0.571 | Fu: | 2.38% |
| CYP1A2-inhibitor: | 0.962 | CYP1A2-substrate: | 0.942 |
| CYP2C19-inhibitor: | 0.797 | CYP2C19-substrate: | 0.489 |
| CYP2C9-inhibitor: | 0.743 | CYP2C9-substrate: | 0.951 |
| CYP2D6-inhibitor: | 0.753 | CYP2D6-substrate: | 0.92 |
| CYP3A4-inhibitor: | 0.888 | CYP3A4-substrate: | 0.495 |
| Clearance (CL): | 11.115 | Half-life (T1/2): | 0.392 |
| hERG Blockers: | 0.07 | Human Hepatotoxicity (H-HT): | 0.164 |
| Drug-inuced Liver Injury (DILI): | 0.663 | AMES Toxicity: | 0.204 |
| Rat Oral Acute Toxicity: | 0.408 | Maximum Recommended Daily Dose: | 0.717 |
| Skin Sensitization: | 0.593 | Carcinogencity: | 0.162 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.408 |
| Respiratory Toxicity: | 0.384 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000700 | ![]() |
0.437 | D07MGA | ![]() |
0.437 | ||
| ENC002461 | ![]() |
0.430 | D06GCK | ![]() |
0.371 | ||
| ENC001772 | ![]() |
0.430 | D0F7CS | ![]() |
0.339 | ||
| ENC000938 | ![]() |
0.409 | D0L1JW | ![]() |
0.333 | ||
| ENC002134 | ![]() |
0.409 | D0AZ8C | ![]() |
0.317 | ||
| ENC001631 | ![]() |
0.409 | D0D4HN | ![]() |
0.307 | ||
| ENC003661 | ![]() |
0.402 | D0W8WB | ![]() |
0.305 | ||
| ENC006013 | ![]() |
0.402 | D0I9HF | ![]() |
0.300 | ||
| ENC002517 | ![]() |
0.402 | D02LZB | ![]() |
0.299 | ||
| ENC001770 | ![]() |
0.386 | D04TDQ | ![]() |
0.296 | ||